Stocks to sell

After months of sideways price action, Covid-19 vaccine play Ocugen (NASDAQ:OCGN) stock is zooming higher once. Source: shutterstock.com/PhotobyTawat The big development is a likely Emergency Use Listing (EUL) from the World Health Organization (WHO) for Covaxin. Developed in India by Bharat Biotech, Ocugen holds the U.S. and Canadian rights to market this vaccine. An EUL certainly

Just over a year ago, Hyliion (NYSE:HYLN) was one of the hottest electric vehicle special-purpose acquisition company (SPAC) plays out there. Just before its “de-SPACing,” excitement over this maker of electric trucks and powertrains briefly sent HYLN stock to prices over $50 per share. Source: Shutterstock Flash forward back to now, and where are shares changing

Wish.com parent company ContextLogic (NASDAQ:WISH) stock has been a disaster since its initial public offering. Source: sdx15 / Shutterstock.com Wish went public at an IPO price of $24 in December 2020. The stock rallied as high as $32.85 in February during the Reddit WallStreetBets trading fury. Since then, the stock has dropped like a rock.

With shares moving up following the acquisition of Nanotech, is it time to buy Meta Materials (NASDAQ:MMAT) stock, ahead of its revenues taking off? Not so fast. It’s still down big from the high prices it hit when it first appeared on the radar of meme stock investors. But at $5.31 per share, this smart

OpenDoor (NASDAQ:OPEN) stock is the kind of name I’ve learned to avoid. Source: PREMIO STOCK/Shutterstock.com Over my years of investing, I’ve learned–in some cases, the hard way — that buying stocks on weakness is really the best and easiest way to make money in the market. Conversely, buying risky names that are riding positive momentum

A few months ago, the Federal Reserve was talking about “transitory” inflation. The governors at the Fed meant that while inflation was rising swiftly, it wasn’t going to last. But inflation kept rising at a brisk clip and the Fed started to be less sanguine about the transitory nature of inflation. It hedged by telling

Ocugen (NASDAQ:OCGN) is a small biotech firm. For years, it tried unsuccessfully to commercialize therapies for eye diseases. However, in 2020, it ended a Phase 3 trial on that front and pivoted to Covid-19. Its first effort in that regard, Covid-19 testing, totally failed to take off. The company is nothing if not persistent, however,

I fully understand why it’s very tempting to buy Alibaba (NASDAQ:BABA) stock at this point. The company’s shares have tumbled a great deal in the last six months, yet the company remains one of the biggest and most successful e-commerce players on the planet, and its cloud business is still growing rapidly. Source: BigTunaOnline /

Tech stocks are hot property in 2021 but that is not the case with Intel (NASDAQ:INTC) stock. Source: Pavel Kapysh / Shutterstock.com The stock started diving a long time ago and has continued to do so for the past few months. INTC stock managed to hit an all-time high of $68 in January 2020 and

Israeli online freelancer platform Fiverr (NYSE:FVRR) is the definition of a mixed bag. The company has some key strengths that are balanced out by some equally important weaknesses. I typically find it’s best to avoid companies like this unless their shares are trading at a very attractive valuation. In the case of FVRR stock, that

It is time for Redditors to rejoice. After battling it out with hedge funds for the better part of a year, we are finally at a point where most short sellers are skeptical of touching GameStop (NYSE:GME) stock. Source: Northfoto / Shutterstock.com The short interest percentage of the total float stands at 16.98%, as of

Zoom Video Communications (NASDAQ:ZM) was one of the prime beneficiaries of the coronavirus pandemic. It closed out 2020 with a colossal run rate of $3.5 million in revenues. However, judging from recent results, its top- and bottom-line growth are slowing as we inch closer to a post-pandemic reality. Moreover, ZM stock is incredibly overvalued based

On Oct. 5, InvestorPlace’s Louis Navellier argued that Ocugen (NASDAQ:OCGN) stock needs a catalyst for it to break free.  Source: shutterstock.com/PhotobyTawat One day earlier, Ocugen appeared to get not one but two catalysts, according to a regulatory filing. As a result, OCGN stock even traded 11% higher in pre-market Oct. 5 trading. Yet by the end

To put it succinctly, there isn’t very much making Lemonade (NYSE:LMND) stock attractive at present. Source: Stephanie L Sanchez / Shutterstock.com Yes, there’s news that the insurance company is launching a new service for pets. That will expand the company’s product mix beyond life, homeowners, and renters insurance. And Lemonade already announced a car insurance

Vinco Ventures (NASDAQ:BBIG) stock began last week at $6.01 and this week just a hair over $5. Source: Shutterstock The loss was despite the announcement that ZVV Media Partners LLC and Zash Global Media had entered into a letter of intent to buy AdRizer LLC for $108 million in cash and stock.  Vinco and Zash

A few months back, ChargePoint (NYSE:CHPT) stock had plenty of positive catalysts that were helping it move higher or, at the very least, hold steady. Not only  was the U.S. bipartisan Infrastructure bill helping to sustain buzz about the shares, but the market was highly favorable to speculative growth stocks. Source: YuniqueB / Shutterstock.com But

Boeing (NYSE:BA) stock has yet to recover from 2018. Source: Alex JW Robinson / Shutterstock.com When the 737-MAX scandal first overtook the company, investors were told to “buy the dip” at $320 per share. After all, BA stock traded at $440. It delivered dividends of more than $2 per share each quarter. Those who bought

Easily the most controversial country over the past year-and-a-half period, China is again making waves. This time, it has taken on the cryptocurrency phenomenon, banning its transactions and its mining operations. Unfortunately, that puts SOS Ltd (NYSE:SOS) stock in quite a bind. Source: Mark Agnor / Shutterstock.com Its own government is enemy No. 1. As

Investors who are still holding onto shares of ContextLogic (NASDAQ:WISH) stock should dump the stock now before there’s nothing left. Source: sdx15 / Shutterstock.com WISH stock plummeted 28% in the last month, bringing its total decline for the year to 71%. It’s flirting with the $5 mark, which would make it a penny stock. Shareholders

My editors asked me to give my 2 cents about SmileDirectClub (NASDAQ:SDC), the direct-to-consumer medtech platform that’s supposed to make your smile look like a million bucks. Unfortunately, for IPO investors, SDC stock has been anything but a millionaire-maker since going public in September 2019 at $23 a share.  Source: Thamyris Salgueiro / Shutterstock.com SDC